Eletrical cardioversion versus defibrillation of atrial fibrilation - a clinical trial

Eletrical cardioversion versus defibrillation of atrial fibrilation - a clinical trial - VCD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00003691

Enrollment

300

Registered

2012-03-29

Start date

2008-02-19

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I48.19

Interventions

Group 1: electrical cardioversion of atrial fibrillation Group 2: defirbrillation of atrial fibrillation

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: all patients independent of the underlying cardiac disease

Exclusion criteria

Exclusion criteria: 1. latent or overt thyroid dysfunction 2. serum potassium levels below 4 mmol/l 3. clotting inhibitionout of range 4. Detection of left atrial thrombus or tumor 5. Lack of patient's competence

Design outcomes

Primary

Measure	Time frame
Induction of ventricular fibbrilation or ventricular tachycardia during treatment	—

Secondary

Measure	Time frame
Incidence of procedural embolism, non sustained ventricular tachycardia, asystole, bradycardia	—

Countries

Germany

Contacts

Public ContactChristian Keller

Klinik III für Innere Medizin Unikliniken Köln

christian.keller@uk-koeln.de0221-47832396

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026